These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
475 related items for PubMed ID: 12844412
1. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome]. Zhang Z, Xie J. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412 [Abstract] [Full Text] [Related]
2. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A. Blood; 2000 Dec 01; 96(12):3932-8. PubMed ID: 11090080 [Abstract] [Full Text] [Related]
3. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes. Bouscary D, De Vos J, Guesnu M, Jondeau K, Viguier F, Melle J, Picard F, Dreyfus F, Fontenay-Roupie M. Leukemia; 1997 Jun 01; 11(6):839-45. PubMed ID: 9177438 [Abstract] [Full Text] [Related]
8. Increased apoptosis in mononucleated cells but not in CD34+ cells in blastic forms of myelodysplastic syndromes. Berger G, Hunault-Berger M, Rachieru P, Fontenay-Roupie M, Baranger L, Ifrah N, Zandecki M. Hematol J; 2001 Jun 01; 2(2):87-96. PubMed ID: 11424000 [Abstract] [Full Text] [Related]
10. A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome. Gersuk GM, Beckham C, Loken MR, Kiener P, Anderson JE, Farrand A, Troutt AB, Ledbetter JA, Deeg HJ. Br J Haematol; 1998 Oct 01; 103(1):176-88. PubMed ID: 9792306 [Abstract] [Full Text] [Related]
15. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes. Sawanobori M, Yamaguchi S, Hasegawa M, Inoue M, Suzuki K, Kamiyama R, Hirokawa K, Kitagawa M. Leuk Res; 2003 Jul 01; 27(7):583-91. PubMed ID: 12681357 [Abstract] [Full Text] [Related]
16. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes. Kalina U, Hofmann WK, Koschmieder S, Wagner S, Kauschat D, Hoelzer D, Ottmann OG. Exp Hematol; 2000 Oct 01; 28(10):1158-63. PubMed ID: 11027834 [Abstract] [Full Text] [Related]
17. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis. Ohshima K, Karube K, Shimazaki K, Kamma H, Suzumiya J, Hamasaki M, Kikuchi M. Leuk Lymphoma; 2003 Aug 01; 44(8):1339-46. PubMed ID: 12952227 [Abstract] [Full Text] [Related]
18. [Expression of G-CSF and GM-CSF receptors on CD34 positive cells in aplastic anemia and myelodysplastic syndrome patients and its significance]. Xu HZ, Li A, Yu Y, Li JF, Liu X, Wang XH, Wang X, Xu GL. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec 01; 16(6):1308-11. PubMed ID: 19099633 [Abstract] [Full Text] [Related]
19. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival. Gupta P, Niehans GA, LeRoy SC, Gupta K, Morrison VA, Schultz C, Knapp DJ, Kratzke RA. Leukemia; 1999 Jan 01; 13(1):44-53. PubMed ID: 10049059 [Abstract] [Full Text] [Related]